Biosciencia News
1.2K views | +0 today
Follow
Biosciencia News
Everyday news through scientist eyes.
www.biosciencia.com
Curated by Biosciencia
Your new post is loading...
Your new post is loading...
Scooped by Biosciencia
Scoop.it!

A Drug Benefitting Families With Fragile X And Autism Is Discontinued

A Drug Benefitting Families With Fragile X And Autism Is Discontinued | Biosciencia News | Scoop.it

For Holly Roo, mother of a child with fragile X syndrome, the drug arbaclofen allowed her son Parker to accomplish the unimaginable: express himself. But after more than 3 years of trials, Seaside Therapeutics, the drug's sole manufacturer discontinued the drug, leaving the Roos and other families dependent on arbaclofen at a loss.

Biosciencia's insight:

One of many families sharing their positive experience with arbaclofen, known experimentally as STX209, a drug for fragile X syndrome and autism, which was discontinued in May.

more...
No comment yet.
Scooped by Biosciencia
Scoop.it!

Ilaris, Childhood Arthritis Drug From Novartis, Wins FDA Approval

Ilaris, Childhood Arthritis Drug From Novartis, Wins FDA Approval | Biosciencia News | Scoop.it
The multinational pharma manufacturer says the FDA has approved Ilaris for the treatment of juvenile arthritis in patients aged 2 years and older.
Biosciencia's insight:

The FDA has approved Ilaris for the treatment of juvenile arthritis in patients aged two years and older.

more...
No comment yet.